Clinical trial
Taurine in Adolescents With Bipolar Disorder
NCT00391001 · Cambridge Health Alliance, Other · Terminated
Key facts
| NCT number | NCT00391001 |
|---|---|
| Title | Taurine in Adolescents With Bipolar Disorder |
| Official title | Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study in Adolescents With Bipolar Disorder |
| Lead sponsor | Cambridge Health Alliance, Other |
| Collaborators | Stanley Medical Research Institute Mclean Hospital |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Taurine |
| Enrollment | 4 |
| Start date | Feb 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Oct 23, 2006 |
| Last update posted | Feb 3, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: